Switching to preservative-free latanoprost: impact on tolerability and patient satisfaction

Abstract

Daniel Edward Robert Beck,1 Karim El-Assal,1 Ken McGarry,2 Nicholas Kloster Wride1 1Sunderland Eye Infirmary, 2Faculty of Health Sciences and Wellbeing, University of Sunderland, Sunderland, UK We read with interest the article by Negrete et al.1 A recent study performed at our unit found similar results on conducting a review of tolerance to preservative-free latanoprost (Monopost) in patients who were unable to tolerate preserved formulae, and we would like to take the opportunity to share the results with you. View the original paper by Negrete and colleagues.  

Keywords

• Glaucoma
• Monopost
• Latanoprost
• Tolerence